Cargando…

Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach

Parkinson’s disease (PD) is one of the most prevalent neurological diseases, described by complex clinical phenotypes. The manifestations of PD include both motor and non-motor symptoms. We constituted an experimental protocol for the assessment of PD motor signs of lower extremities. Using a pair o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatzaki, Chariklia, Skaramagkas, Vasileios, Kefalopoulou, Zinovia, Tachos, Nikolaos, Kostikis, Nicholas, Kanellos, Foivos, Triantafyllou, Eleftherios, Chroni, Elisabeth, Fotiadis, Dimitrios I., Tsiknakis, Manolis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787905/
https://www.ncbi.nlm.nih.gov/pubmed/36560313
http://dx.doi.org/10.3390/s22249937
_version_ 1784858625432354816
author Chatzaki, Chariklia
Skaramagkas, Vasileios
Kefalopoulou, Zinovia
Tachos, Nikolaos
Kostikis, Nicholas
Kanellos, Foivos
Triantafyllou, Eleftherios
Chroni, Elisabeth
Fotiadis, Dimitrios I.
Tsiknakis, Manolis
author_facet Chatzaki, Chariklia
Skaramagkas, Vasileios
Kefalopoulou, Zinovia
Tachos, Nikolaos
Kostikis, Nicholas
Kanellos, Foivos
Triantafyllou, Eleftherios
Chroni, Elisabeth
Fotiadis, Dimitrios I.
Tsiknakis, Manolis
author_sort Chatzaki, Chariklia
collection PubMed
description Parkinson’s disease (PD) is one of the most prevalent neurological diseases, described by complex clinical phenotypes. The manifestations of PD include both motor and non-motor symptoms. We constituted an experimental protocol for the assessment of PD motor signs of lower extremities. Using a pair of sensor insoles, data were recorded from PD patients, Elderly and Adult groups. Assessment of PD patients has been performed by neurologists specialized in movement disorders using the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)-Part III: Motor Examination, on both ON and OFF medication states. Using as a reference point the quantified metrics of MDS-UPDRS-Part III, severity levels were explored by classifying normal, mild, moderate, and severe levels of PD. Elaborating the recorded gait data, 18 temporal and spatial characteristics have been extracted. Subsequently, feature selection techniques were applied to reveal the dominant features to be used for four classification tasks. Specifically, for identifying relations between the spatial and temporal gait features on: PD and non-PD groups; PD, Elderly and Adults groups; PD and ON/OFF medication states; MDS-UPDRS: Part III and PD severity levels. AdaBoost, Extra Trees, and Random Forest classifiers, were trained and tested. Results showed a recognition accuracy of 88%, 73% and 81% for, the PD and non-PD groups, PD-related medication states, and PD severity levels relevant to MDS-UPDRS: Part III ratings, respectively.
format Online
Article
Text
id pubmed-9787905
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97879052022-12-24 Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach Chatzaki, Chariklia Skaramagkas, Vasileios Kefalopoulou, Zinovia Tachos, Nikolaos Kostikis, Nicholas Kanellos, Foivos Triantafyllou, Eleftherios Chroni, Elisabeth Fotiadis, Dimitrios I. Tsiknakis, Manolis Sensors (Basel) Article Parkinson’s disease (PD) is one of the most prevalent neurological diseases, described by complex clinical phenotypes. The manifestations of PD include both motor and non-motor symptoms. We constituted an experimental protocol for the assessment of PD motor signs of lower extremities. Using a pair of sensor insoles, data were recorded from PD patients, Elderly and Adult groups. Assessment of PD patients has been performed by neurologists specialized in movement disorders using the Movement Disorder Society—Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)-Part III: Motor Examination, on both ON and OFF medication states. Using as a reference point the quantified metrics of MDS-UPDRS-Part III, severity levels were explored by classifying normal, mild, moderate, and severe levels of PD. Elaborating the recorded gait data, 18 temporal and spatial characteristics have been extracted. Subsequently, feature selection techniques were applied to reveal the dominant features to be used for four classification tasks. Specifically, for identifying relations between the spatial and temporal gait features on: PD and non-PD groups; PD, Elderly and Adults groups; PD and ON/OFF medication states; MDS-UPDRS: Part III and PD severity levels. AdaBoost, Extra Trees, and Random Forest classifiers, were trained and tested. Results showed a recognition accuracy of 88%, 73% and 81% for, the PD and non-PD groups, PD-related medication states, and PD severity levels relevant to MDS-UPDRS: Part III ratings, respectively. MDPI 2022-12-16 /pmc/articles/PMC9787905/ /pubmed/36560313 http://dx.doi.org/10.3390/s22249937 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chatzaki, Chariklia
Skaramagkas, Vasileios
Kefalopoulou, Zinovia
Tachos, Nikolaos
Kostikis, Nicholas
Kanellos, Foivos
Triantafyllou, Eleftherios
Chroni, Elisabeth
Fotiadis, Dimitrios I.
Tsiknakis, Manolis
Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach
title Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach
title_full Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach
title_fullStr Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach
title_full_unstemmed Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach
title_short Can Gait Features Help in Differentiating Parkinson’s Disease Medication States and Severity Levels? A Machine Learning Approach
title_sort can gait features help in differentiating parkinson’s disease medication states and severity levels? a machine learning approach
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787905/
https://www.ncbi.nlm.nih.gov/pubmed/36560313
http://dx.doi.org/10.3390/s22249937
work_keys_str_mv AT chatzakichariklia cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT skaramagkasvasileios cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT kefalopoulouzinovia cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT tachosnikolaos cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT kostikisnicholas cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT kanellosfoivos cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT triantafylloueleftherios cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT chronielisabeth cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT fotiadisdimitriosi cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach
AT tsiknakismanolis cangaitfeatureshelpindifferentiatingparkinsonsdiseasemedicationstatesandseveritylevelsamachinelearningapproach